ReP USP - Resultado da busca

Artigo de periodico
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease (2016)
Bonaca, Marc P.; Bhatt, Deepak L.; Storey, Robert F.; Steg, Gabriel; Cohen, Marc; Kuder, Julia; Goodrich, Erica; Nicolau, José C.; Parkhomenko, Alexander; López-Sendón, José; Dellborg, Mikael; Dalby, Anthony; Špinar, Jindřich; Aylward, Philip; Corbalán, Ramón; Abola, Maria Teresa B.; Jensen, Eva C.; Held, Peter; Braunwald, Eugene; Sabatine Marc S.
Source: Journal of the American College of Cardiology. Unidade: FM
Subjects: PLACEBO, FÁRMACOS (SISTEMA CARDIOVASCULAR), DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONACA, Marc P. et al. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology, v. 67, n. 23, p. 2719-2728, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2016.03.524. Acesso em: 07 nov. 2024.
APA
Bonaca, M. P., Bhatt, D. L., Storey, R. F., Steg, G., Cohen, M., Kuder, J., et al. (2016). Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. Journal of the American College of Cardiology, 67( 23), 2719-2728. doi:10.1016/j.jacc.2016.03.524
NLM
Bonaca MP, Bhatt DL, Storey RF, Steg G, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, Abola MTB, Jensen EC, Held P, Braunwald E, Sabatine Marc S. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 23): 2719-2728.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2016.03.524
Vancouver
Bonaca MP, Bhatt DL, Storey RF, Steg G, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, Abola MTB, Jensen EC, Held P, Braunwald E, Sabatine Marc S. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 23): 2719-2728.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.jacc.2016.03.524
Artigo de periodico
Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial (2015)
Udell, Jacob A.; Bhatt, Deepak L.; Braunwald, Eugene; Cavender, Matthew A.; Mosenzon, Ofri; Steg, Gabriel; Davidson, Jaime A.; Nicolau, Jose C.; Corbalan, Ramon; Hirshberg, Boaz; Frederich, Robert; Im, KyungAh; Umez-Eronini, Amarachi A.; He, Ping; McGuire, Darren K.; Leiter, Lawrence A.; Raz, Itamar; Scirica, Benjamin M.
Source: Diabetes Care. Unidade: FM
Subjects: DIABTES MELLITUS (COMPLICAÇÕES), FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, INIBIDORES DE ENZIMAS, NEOPLASIAS (ETIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UDELL, Jacob A. et al. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care, v. 38, n. 4, p. 696-705, 2015Tradução . . Disponível em: https://doi.org/10.2337/dc14-1850. Acesso em: 07 nov. 2024.
APA
Udell, J. A., Bhatt, D. L., Braunwald, E., Cavender, M. A., Mosenzon, O., Steg, G., et al. (2015). Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial. Diabetes Care, 38( 4), 696-705. doi:10.2337/dc14-1850
NLM
Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg G, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im KA, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial [Internet]. Diabetes Care. 2015 ; 38( 4): 696-705.[citado 2024 nov. 07 ] Available from: https://doi.org/10.2337/dc14-1850
Vancouver
Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg G, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im KA, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial [Internet]. Diabetes Care. 2015 ; 38( 4): 696-705.[citado 2024 nov. 07 ] Available from: https://doi.org/10.2337/dc14-1850
Artigo de periodico
The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial (2014)
Husted, Steen; James, Stefan K.; Bach, Richard G.; Becker, Richard C.; Budaj, Andrzej; Heras, Magda; Himmelmann, Anders; Horrow, Jay; Katus, Hugo A.; Lassila, Riita; Morais, Joao; Nicolau, José C.; Steg, Gabriel; Storey, Robert F.; Wojdyla, Daniel; Wallentin, Lars
Source: European heart journal. Unidade: FM
Subjects: TROMBOSE, SEXO, SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUSTED, Steen et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, v. 35, n. 23, p. 1541-1550, 2014Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehu075. Acesso em: 07 nov. 2024.
APA
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., et al. (2014). The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, 35( 23), 1541-1550. doi:10.1093/eurheartj/ehu075
NLM
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/eurheartj/ehu075
Vancouver
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1093/eurheartj/ehu075
Artigo de periodico
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors (2013)
Barthélémy, Olivier; Limbourg, Tobias; Collet, Jean Philippe; Beygui, Farzin; Silvain, Johanne; Bellemain-Appaix, Anne; Cayla, Guillaume; Chastre, Thomas; Baumgartner, Iris; Röther, Joachim; Zeymer, Uwe; Bhatt, Deepak L.; Steg, Gabriel; Montalescot, Gilles; Pazin Filho, Antonio; Maciel, Léa Maria Zanini
Source: International Journal of Cardiology. Unidade: FMRP
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, INFARTO DO MIOCÁRDIO, ACIDENTE VASCULAR CEREBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARTHÉLÉMY, Olivier et al. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. International Journal of Cardiology, v. 163, n. 3, p. 266-271, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2011.06.015. Acesso em: 07 nov. 2024.
APA
Barthélémy, O., Limbourg, T., Collet, J. P., Beygui, F., Silvain, J., Bellemain-Appaix, A., et al. (2013). Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. International Journal of Cardiology, 163( 3), 266-271. doi:10.1016/j.ijcard.2011.06.015
NLM
Barthélémy O, Limbourg T, Collet JP, Beygui F, Silvain J, Bellemain-Appaix A, Cayla G, Chastre T, Baumgartner I, Röther J, Zeymer U, Bhatt DL, Steg G, Montalescot G, Pazin Filho A, Maciel LMZ. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [Internet]. International Journal of Cardiology. 2013 ; 163( 3): 266-271.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ijcard.2011.06.015
Vancouver
Barthélémy O, Limbourg T, Collet JP, Beygui F, Silvain J, Bellemain-Appaix A, Cayla G, Chastre T, Baumgartner I, Röther J, Zeymer U, Bhatt DL, Steg G, Montalescot G, Pazin Filho A, Maciel LMZ. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [Internet]. International Journal of Cardiology. 2013 ; 163( 3): 266-271.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ijcard.2011.06.015
Artigo de periodico
Risk factors and outcomes for patients with vascular disease and serious bleeding events (2011)
Alberts, Mark J.; Bhatt, Deepak L.; Smith Jr., Sidney C.; Röther, Joachim; Goto, Shinya; Hirsch, Alan T.; Steg, Gabriel; Pazin Filho, Antonio
Source: Heart. Unidade: FMRP
Subjects: DOENÇAS VASCULARES, FATORES DE RISCO, HEMORRAGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBERTS, Mark J. et al. Risk factors and outcomes for patients with vascular disease and serious bleeding events. Heart, v. 97, n. 18, p. 1507-1512, 2011Tradução . . Disponível em: https://doi.org/10.1136/hrt.2010.221788. Acesso em: 07 nov. 2024.
APA
Alberts, M. J., Bhatt, D. L., Smith Jr., S. C., Röther, J., Goto, S., Hirsch, A. T., et al. (2011). Risk factors and outcomes for patients with vascular disease and serious bleeding events. Heart, 97( 18), 1507-1512. doi:10.1136/hrt.2010.221788
NLM
Alberts MJ, Bhatt DL, Smith Jr. SC, Röther J, Goto S, Hirsch AT, Steg G, Pazin Filho A. Risk factors and outcomes for patients with vascular disease and serious bleeding events [Internet]. Heart. 2011 ; 97( 18): 1507-1512.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1136/hrt.2010.221788
Vancouver
Alberts MJ, Bhatt DL, Smith Jr. SC, Röther J, Goto S, Hirsch AT, Steg G, Pazin Filho A. Risk factors and outcomes for patients with vascular disease and serious bleeding events [Internet]. Heart. 2011 ; 97( 18): 1507-1512.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1136/hrt.2010.221788
Artigo de periodico
Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease (2011)
Keo, Hong H.; Baumgartner, Iris; Hirsch, Alan T.; Duval, Sue; Steg, Gabriel; Pasquet, Blandine; Bhatt, Deepak; Roether, Joachim; Pazin Filho, Antonio; Maciel, Léa Maria Zanini
Source: Vascular Medicine. Unidade: FMRP
Subjects: ARTÉRIAS CARÓTIDAS, DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE, ULTRASSONOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KEO, Hong H. et al. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease. Vascular Medicine, v. 16, n. 5, p. 323-330, 2011Tradução . . Disponível em: https://doi.org/10.1177/1358863X11419997. Acesso em: 07 nov. 2024.
APA
Keo, H. H., Baumgartner, I., Hirsch, A. T., Duval, S., Steg, G., Pasquet, B., et al. (2011). Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease. Vascular Medicine, 16( 5), 323-330. doi:10.1177/1358863X11419997
NLM
Keo HH, Baumgartner I, Hirsch AT, Duval S, Steg G, Pasquet B, Bhatt D, Roether J, Pazin Filho A, Maciel LMZ. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease [Internet]. Vascular Medicine. 2011 ; 16( 5): 323-330.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1177/1358863X11419997
Vancouver
Keo HH, Baumgartner I, Hirsch AT, Duval S, Steg G, Pasquet B, Bhatt D, Roether J, Pazin Filho A, Maciel LMZ. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease [Internet]. Vascular Medicine. 2011 ; 16( 5): 323-330.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1177/1358863X11419997
Artigo de periodico
One-year cardiovascular event rates in outpatients with atherothrombosis (2007)
Steg, Gabriel; Bhatt, Deepak L.; Wilson, Peter W. F.; D'Agostino, Ralph; Ohman, E. Magnus; Röther, Joachim; Liau, Chiau-Suong; Hirsch, Alan T.; Mas, Jean-Louis; Ikeda, Yasuo; Pencina, Michael J.; Goto, Shinya; Maciel, Léa Maria Zanini; Pazin-Filho, Antonio
Source: Jama - The Journal of the American Medical Association. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STEG, Gabriel et al. One-year cardiovascular event rates in outpatients with atherothrombosis. Jama - The Journal of the American Medical Association, v. 297, n. 11, p. 1197-1206, 2007Tradução . . Acesso em: 07 nov. 2024.
APA
Steg, G., Bhatt, D. L., Wilson, P. W. F., D'Agostino, R., Ohman, E. M., Röther, J., et al. (2007). One-year cardiovascular event rates in outpatients with atherothrombosis. Jama - The Journal of the American Medical Association, 297( 11), 1197-1206.
NLM
Steg G, Bhatt DL, Wilson PWF, D'Agostino R, Ohman EM, Röther J, Liau C-S, Hirsch AT, Mas J-L, Ikeda Y, Pencina MJ, Goto S, Maciel LMZ, Pazin-Filho A. One-year cardiovascular event rates in outpatients with atherothrombosis. Jama - The Journal of the American Medical Association. 2007 ; 297( 11): 1197-1206.[citado 2024 nov. 07 ]
Vancouver
Steg G, Bhatt DL, Wilson PWF, D'Agostino R, Ohman EM, Röther J, Liau C-S, Hirsch AT, Mas J-L, Ikeda Y, Pencina MJ, Goto S, Maciel LMZ, Pazin-Filho A. One-year cardiovascular event rates in outpatients with atherothrombosis. Jama - The Journal of the American Medical Association. 2007 ; 297( 11): 1197-1206.[citado 2024 nov. 07 ]
Artigo de periodico
The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design (2006)
Ohman, E. Magnus; Bhatt, Deepak L.; Steg, Gabriel; Goto, Shinya; MedSci, D.; Hirsch, Alan T.; Mas, Jean-Louis; Richard, Alain-Jean; Röther, Joachim; Wilson, Peter W. F.; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: American Heart Journal. Unidade: FMRP
Subjects: DOENÇAS VASCULARES, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design. American Heart Journal, v. 151, p. 786.e1 - 786.e10, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2005.11.004. Acesso em: 07 nov. 2024.
APA
Ohman, E. M., Bhatt, D. L., Steg, G., Goto, S., MedSci, D., Hirsch, A. T., et al. (2006). The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design. American Heart Journal, 151, 786.e1 - 786.e10. doi:10.1016/j.ahj.2005.11.004
NLM
Ohman EM, Bhatt DL, Steg G, Goto S, MedSci D, Hirsch AT, Mas J-L, Richard A-J, Röther J, Wilson PWF, Maciel LMZ, Pazin Filho A. The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design [Internet]. American Heart Journal. 2006 ; 151 786.e1 - 786.e10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ahj.2005.11.004
Vancouver
Ohman EM, Bhatt DL, Steg G, Goto S, MedSci D, Hirsch AT, Mas J-L, Richard A-J, Röther J, Wilson PWF, Maciel LMZ, Pazin Filho A. The reduction of atherothrombosis for continued health (REACH) registry: an international, prespective, observational investigation in subjects at risk for atherothrombotic events-study design [Internet]. American Heart Journal. 2006 ; 151 786.e1 - 786.e10.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1016/j.ahj.2005.11.004

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Indexado em

Non normalized affiliation